協和キリンの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2017/10/12 | 1,984 | 1,984 | 1,965 | 1,966 | -12 | -0.6% | 710,800 |
| 2017/10/11 | 1,942 | 1,982 | 1,940 | 1,978 | +23 | +1.2% | 750,900 |
| 2017/10/10 | 1,939 | 1,956 | 1,928 | 1,955 | -5 | -0.3% | 914,000 |
| 2017/10/06 | 1,969 | 1,969 | 1,948 | 1,960 | ±0 | ±0% | 906,400 |
| 2017/10/05 | 1,960 | 1,961 | 1,946 | 1,960 | ±0 | ±0% | 738,900 |
| 2017/10/04 | 1,965 | 1,975 | 1,955 | 1,960 | -6 | -0.3% | 932,700 |
| 2017/10/03 | 1,918 | 1,968 | 1,908 | 1,966 | +52 | +2.7% | 1,312,200 |
| 2017/10/02 | 1,930 | 1,944 | 1,909 | 1,914 | ±0 | ±0% | 1,550,200 |
| 2017/09/29 | 1,882 | 1,914 | 1,875 | 1,914 | +26 | +1.4% | 1,493,400 |
| 2017/09/28 | 1,900 | 1,902 | 1,881 | 1,888 | -17 | -0.9% | 1,428,100 |
| 2017/09/27 | 1,937 | 1,948 | 1,892 | 1,905 | -11 | -0.6% | 1,230,300 |
| 2017/09/26 | 1,884 | 1,918 | 1,881 | 1,916 | +28 | +1.5% | 1,154,100 |
| 2017/09/25 | 1,894 | 1,897 | 1,874 | 1,888 | +11 | +0.6% | 1,291,800 |
| 2017/09/22 | 1,873 | 1,880 | 1,859 | 1,877 | +18 | +1% | 955,400 |
| 2017/09/21 | 1,852 | 1,877 | 1,848 | 1,859 | +16 | +0.9% | 1,012,900 |
| 2017/09/20 | 1,848 | 1,862 | 1,838 | 1,843 | -21 | -1.1% | 1,078,600 |
| 2017/09/19 | 1,847 | 1,867 | 1,842 | 1,864 | +26 | +1.4% | 1,325,100 |
| 2017/09/15 | 1,854 | 1,860 | 1,831 | 1,838 | -10 | -0.5% | 1,487,900 |
| 2017/09/14 | 1,891 | 1,896 | 1,848 | 1,848 | -58 | -3% | 1,411,400 |
| 2017/09/13 | 1,883 | 1,914 | 1,875 | 1,906 | +34 | +1.8% | 1,255,400 |
| 2017/09/12 | 1,872 | 1,877 | 1,853 | 1,872 | +17 | +0.9% | 992,700 |
| 2017/09/11 | 1,835 | 1,861 | 1,828 | 1,855 | +49 | +2.7% | 1,216,200 |
| 2017/09/08 | 1,786 | 1,818 | 1,785 | 1,806 | -9 | -0.5% | 2,609,400 |
| 2017/09/07 | 1,844 | 1,849 | 1,806 | 1,815 | -47 | -2.5% | 1,529,900 |
| 2017/09/06 | 1,853 | 1,869 | 1,838 | 1,862 | +11 | +0.6% | 1,010,500 |
| 2017/09/05 | 1,860 | 1,862 | 1,844 | 1,851 | -15 | -0.8% | 950,900 |
| 2017/09/04 | 1,919 | 1,924 | 1,865 | 1,866 | -83 | -4.3% | 1,467,000 |
| 2017/09/01 | 1,955 | 1,963 | 1,935 | 1,949 | +18 | +0.9% | 975,800 |
| 2017/08/31 | 1,905 | 1,939 | 1,904 | 1,931 | +35 | +1.8% | 1,081,800 |
| 2017/08/30 | 1,879 | 1,905 | 1,876 | 1,896 | +34 | +1.8% | 1,197,000 |
| 2017/08/29 | 1,855 | 1,866 | 1,848 | 1,862 | -8 | -0.4% | 655,300 |
| 2017/08/28 | 1,847 | 1,873 | 1,846 | 1,870 | +35 | +1.9% | 875,200 |
| 2017/08/25 | 1,866 | 1,871 | 1,829 | 1,835 | -25 | -1.3% | 1,176,100 |
| 2017/08/24 | 1,880 | 1,881 | 1,857 | 1,860 | -33 | -1.7% | 721,000 |
| 2017/08/23 | 1,895 | 1,905 | 1,882 | 1,893 | +17 | +0.9% | 836,700 |
| 2017/08/22 | 1,851 | 1,879 | 1,848 | 1,876 | +9 | +0.5% | 897,400 |
| 2017/08/21 | 1,877 | 1,888 | 1,856 | 1,867 | ±0 | ±0% | 961,800 |
| 2017/08/18 | 1,884 | 1,895 | 1,861 | 1,867 | -38 | -2% | 1,558,600 |
| 2017/08/17 | 1,922 | 1,929 | 1,903 | 1,905 | -23 | -1.2% | 1,095,500 |
| 2017/08/16 | 1,932 | 1,935 | 1,909 | 1,928 | -3 | -0.2% | 1,112,600 |
| 2017/08/15 | 1,934 | 1,950 | 1,918 | 1,931 | +10 | +0.5% | 924,000 |
| 2017/08/14 | 1,950 | 1,951 | 1,920 | 1,921 | -54 | -2.7% | 1,113,500 |
| 2017/08/10 | 1,979 | 1,989 | 1,962 | 1,975 | +5 | +0.3% | 656,000 |
| 2017/08/09 | 1,971 | 1,993 | 1,962 | 1,970 | -10 | -0.5% | 850,500 |
| 2017/08/08 | 1,999 | 1,999 | 1,977 | 1,980 | -27 | -1.3% | 932,200 |
| 2017/08/07 | 2,024 | 2,024 | 2,005 | 2,007 | -18 | -0.9% | 882,400 |
| 2017/08/04 | 2,002 | 2,031 | 1,988 | 2,025 | +15 | +0.7% | 926,000 |
| 2017/08/03 | 2,002 | 2,017 | 2,002 | 2,010 | -4 | -0.2% | 907,900 |
| 2017/08/02 | 2,002 | 2,031 | 2,000 | 2,014 | +1 | ±0% | 915,500 |
| 2017/08/01 | 1,992 | 2,034 | 1,986 | 2,013 | +11 | +0.5% | 1,473,000 |
1851～
1900
件表示中 / 3699件
類似銘柄と比較する
現在ご覧いただいている「協和キリン」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 協和キリン | 217,200円 | -3.5% | -11.3% | 2.76% | 19.95倍 | 1.34倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
| アステラス薬 | 134,100円 | +0.9% | +380.2% | 5.82% | 18.47倍 | 1.59倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
| 塩野義 | 218,800円 | +20.9% | +10.6% | 3.02% | 10.34倍 | 1.37倍 |
|
抗ＨＩＶ薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
| エーザイ | 366,700円 | +1.7% | -2.9% | 4.36% | 24.06倍 | 1.27倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
| 小野薬 | 149,200円 | +0.6% | +43.3% | 5.36% | 10.46倍 | 0.89倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
市場注目の銘柄
チャート関連のコラム
